Investigating how Epstein-Barr Virus contributes to certain cancers
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
This study is looking into how the Epstein-Barr Virus might contribute to certain types of cancers, like stomach and throat cancer, to find new ways to treat these diseases and help those affected.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wistar Institute NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11085157 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of Epstein-Barr Virus (EBV) in causing epithelial cancers, which are linked to over 200,000 new cancer cases annually. The project aims to explore the mechanisms through which EBV influences cancer development, particularly in gastric and nasopharyngeal carcinomas. By examining the interplay between viral infection, genetic mutations, and metabolic changes, the research team seeks to identify potential therapeutic targets. The collaborative effort involves experts in virology, cancer biology, and drug discovery to develop new treatment strategies for these challenging cancers.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with EBV-associated epithelial cancers, such as gastric carcinoma or nasopharyngeal carcinoma.
Not a fit: Patients with cancers not associated with Epstein-Barr Virus or those without epithelial cancer types may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted therapies for EBV-associated epithelial cancers, improving patient outcomes.
How similar studies have performed: While the specific approach of targeting EBV-related cancers is innovative, there have been successful studies exploring viral contributions to cancer, indicating potential for this research.
Where this research is happening
Philadelphia, United States
- Wistar Institute — Philadelphia, United States (Active)
Researchers
- Principal investigator: Lieberman, Paul M. — Wistar Institute
- Study coordinator: Lieberman, Paul M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.